Iridex (IRIX) Notes Payables (2011 - 2024)
Iridex (IRIX) recorded quarterly Notes Payables of $1.7 million in Q4 2024, up 31.96% quarter-over-quarter from $1.3 million in Q3 2024.
Iridex (IRIX) Notes Payables (2011 - 2024) Analysis & Trends
Iridex's Notes Payables history runs 7 years deep, the most recent figure standing at $1.7 million for Q4 2024.
- In Q4 2024, Notes Payables changed N/A year-over-year to $1.7 million; the TTM figure through Dec 2024 stood at $1.7 million (changed N/A YoY), while the FY2024 annual figure was $1.7 million, changed N/A from the prior year.
- Notes Payables was $1.7 million for Q4 2024 at Iridex, up from $1.3 million in the prior quarter.
- In the past five years, Notes Payables ranged from a high of $1.7 million in Q4 2024 to a low of $1.3 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Iridex | 19.91 Mn | 15.31 Mn | 4.74 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 28, 2024 | 1.73 Mn |
| Sep 28, 2024 | 1.31 Mn |
| Dec 30, 2017 | 509,000.00 |
| Dec 31, 2016 | 496,000.00 |
| Jan 2, 2016 | 336,000.00 |
| Jan 3, 2015 | 500,000.00 |
| Dec 28, 2013 | 200,000.00 |
| Dec 29, 2012 | 158,000.00 |
| Dec 31, 2011 | 117,000.00 |